Jefferies upgrades Australia's Sigma Healthcare to 'buy' on growth prospects

Sigma Healthcare

19/03/2026 23:12

** Analysts at Jefferies upgrade Australia's pharmaceutical wholesaler Sigma Healthcare SIG.AX to "buy" from "hold"; PT unchanged at A$3.05

** Brokerage expects margin expansion for SIG in FY26 due to volume growth on fixed-cost base, improvements in company's wholesaling and growth in higher-margin generics

** Higher sales volumes of tirzepatide and Wegovy in H1FY26 to partially continue into H2FY26 - Jefferies

** 10 out of 13 analysts rate the stock "buy" or higher, 3 "hold" - data compiled by LSEG

** Shares down 9.5% YTD

(Reporting by Keshav Singh Chundawat in Bengaluru)

((Keshav.singhchundawat@thomsonreuters.com))